Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...

Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Researchers believe nearly 25,000 hospital visits occurred ... and constipation. The known risks associated with use of Ozempic are reflected in the FDA-approved product labeling." ...

The team reviewed electronic health records (EHRs) from more than 100 million patients in the US, including over 20,000 who were taking Ozempic. They looked at their risk of developing ...

The lawsuit accuses drug manufacturer Novo Nordisk of failing to warn patients of the possible association between the ...

Recent research suggests that Ozempic and other GLP-1 receptor agonists, commonly used for weight loss, may offer unexpected ...

Notably, the authors did not know whether people who visited the hospital were taking Ozempic, Wegovy ... medications to decrease hypoglycemia risk,” they wrote. “Additionally, when evaluating ...

As summer approaches, millions of Americans are turning to weight-loss injections in hopes of shedding pounds—fast. Roughly ...

In Australia, Ozempic is approved for the treatment of ... But these drugs do expire after a few weeks, and microdosing could increase the risk of inadvertently using them after their expiration ...

Merita Emini-Sadiku, who heads the Kosovo university hospital's endocrinology ... Given the risk of side effects, Emini-Sadiku said Ozempic was "by no means to be taken without a doctor's ...